The Latest Breaking News from MRK

Despite the recent wild swings in the stock market, experts believe stocks to stabilize next year. However, as uncertainties remain, new investors should consider investing in stocks that offer compelling yields, such as Merck & Co (MRK) and Verizon Communications (VZ). Keep reading….

The pharmaceutical industry is well-positioned to witness substantial growth, driven by the prevalence of chronic diseases, the aging population, and increased healthcare spending. Given the industry’s promising growth prospects, we think it could be wise to invest in fundamentally sound pharmaceutical stocks Johnson & Johnson (JNJ), Merck & Co (MRK),…

The best mutual funds scooped up shares of MRK, LLY, ABBV and AMGN, while also adding retailers like WING to their holiday lists

The Fed’s aggressive monetary policy stance has created widespread recession possibilities for next year. However, stable consumer spending and a hot labor market shows signs of a resilient economy. Amid this scenario, Wall Street favorites Microsoft (MSFT), and Merck & Co. (MRK) could be worth buying, considering their fundamental strength.…

Healthcare company Merck & Co. (MRK) is set to acquire Imago BioSciences (IMGO) for more than $1 billion. The stock has gained more than 40% this year. However, given the macroeconomic headwinds, would it be wise to buy the stock now? Read on to find out….

After signs of cooling inflation, investors are hopeful that the Fed will slow its rate hikes over the coming months. With surging optimism, fundamentally strong stocks Merck (MRK), Coca-Cola (KO), and Verizon (VZ), which have seen increased insider buying, might be ideal investments now. Continue reading.

With strong indications of slowing interest rate hikes by the Fed poised to feed the stock market rally, it could be wise to invest in Merck (MRK), AT&T (T), Mosaic (MOS), and Photronics (PLAB), which are in vogue on Wall Street. Continue reading….

The Federal Reserve is expected to lower the pace of its rate hikes from next month. However, concerns about an economic slowdown are still evident. Hence, this might be the time to follow the smart money and buy Merck (MRK) and Yelp (YELP). Institutions own the majority of shares of…

With the Fed indicating that the final level of interest rates will be higher than expected, many analysts expect the economy to slip into a recession next year. Since the stock market will likely remain under pressure, investors should consider buying fundamentally strong stocks UnitedHealth Group (UNH), Merck & Co.…

The latest CPI report shows signs of a cooling down inflation. On the other hand, the healthcare market is expected to boom amid increasing health awareness and technological advancements. Hence, we think fundamentally robust healthcare stocks Merck & Co. (MRK) and Elevance Health (ELV) could be solid investments now. Read…

The healthcare industry tends to withstand challenging macro conditions relatively well, as it enjoys inelastic demand for its products and services. And given the solid long-term prospects of the industry, it could be wise to load up fundamentally sound medical stocks Johnson & Johnson (JNJ), AbbVie (ABBV), and Merck (MRK)…